 | • レポートコード：QYR9NV02460 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、シャーガス病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Cz-007、Cz-008、D-121、DNDI-0690、EPLBS-1246、EPLBS-967、その他に、用途別には、病院、診療所、その他にセグメント区分し、シャーガス病薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・シャーガス病薬の世界市場概要 ・シャーガス病薬の製造コスト構成分析 ・シャーガス病薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・シャーガス病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・シャーガス病薬のセグメント分析（種類別） （Cz-007、Cz-008、D-121、DNDI-0690、EPLBS-1246、EPLBS-967、その他） ・シャーガス病薬のセグメント分析（用途別） （病院、診療所、その他） ・シャーガス病薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （AstraZeneca Plc、Bayer AG、Daiichi Sankyo Co Ltd、Eisai Co Ltd、GlaxoSmithKline Plc、Grupo Praxis Pharmaceutical SA、Humanigen Inc、Kancera AB、Merck & Co Inc、Novartis AG、Oblita Therapeutics BVBA、Sanofi、） ・シャーガス病薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Chagas Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Chagas Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Chagas Disease Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Chagas Disease Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Chagas Disease Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AstraZeneca Plc
Bayer AG
Daiichi Sankyo Co Ltd
Eisai Co Ltd
GlaxoSmithKline Plc
Grupo Praxis Pharmaceutical SA
Humanigen Inc
Kancera AB
Merck & Co Inc
Novartis AG
Oblita Therapeutics BVBA
Sanofi
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Cz-007
Cz-008
D-121
DNDI-0690
EPLBS-1246
EPLBS-967
Others
Segment by Application
Hospital
Clinic
Others
Table of Contents
Executive Summary
1 Industry Overview of Chagas Disease Drug
1.1 Definition of Chagas Disease Drug
1.2 Chagas Disease Drug Segment by Type
1.2.1 Global Chagas Disease Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Cz-007
1.2.3 Cz-008
1.2.4 D-121
1.2.5 DNDI-0690
1.2.6 EPLBS-1246
1.2.7 EPLBS-967
1.2.8 Others
1.3 Chagas Disease Drug Segment by Applications
1.3.1 Global Chagas Disease Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Chagas Disease Drug Overall Market
1.4.1 Global Chagas Disease Drug Revenue (2014-2025)
1.4.2 Global Chagas Disease Drug Production (2014-2025)
1.4.3 North America Chagas Disease Drug Status and Prospect (2014-2025)
1.4.4 Europe Chagas Disease Drug Status and Prospect (2014-2025)
1.4.5 China Chagas Disease Drug Status and Prospect (2014-2025)
1.4.6 Japan Chagas Disease Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Chagas Disease Drug Status and Prospect (2014-2025)
1.4.8 India Chagas Disease Drug Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Chagas Disease Drug
2.3 Manufacturing Process Analysis of Chagas Disease Drug
2.4 Industry Chain Structure of Chagas Disease Drug
3 Development and Manufacturing Plants Analysis of Chagas Disease Drug
3.1 Capacity and Commercial Production Date
3.2 Global Chagas Disease Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Chagas Disease Drug
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Chagas Disease Drug Production and Capacity Analysis
4.2 Chagas Disease Drug Revenue Analysis
4.3 Chagas Disease Drug Price Analysis
4.4 Market Concentration Degree
5 Chagas Disease Drug Regional Market Analysis
5.1 Chagas Disease Drug Production by Regions
5.1.1 Global Chagas Disease Drug Production by Regions
5.1.2 Global Chagas Disease Drug Revenue by Regions
5.2 Chagas Disease Drug Consumption by Regions
5.3 North America Chagas Disease Drug Market Analysis
5.3.1 North America Chagas Disease Drug Production
5.3.2 North America Chagas Disease Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Chagas Disease Drug Import and Export
5.4 Europe Chagas Disease Drug Market Analysis
5.4.1 Europe Chagas Disease Drug Production
5.4.2 Europe Chagas Disease Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Chagas Disease Drug Import and Export
5.5 China Chagas Disease Drug Market Analysis
5.5.1 China Chagas Disease Drug Production
5.5.2 China Chagas Disease Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Chagas Disease Drug Import and Export
5.6 Japan Chagas Disease Drug Market Analysis
5.6.1 Japan Chagas Disease Drug Production
5.6.2 Japan Chagas Disease Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Chagas Disease Drug Import and Export
5.7 Southeast Asia Chagas Disease Drug Market Analysis
5.7.1 Southeast Asia Chagas Disease Drug Production
5.7.2 Southeast Asia Chagas Disease Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Chagas Disease Drug Import and Export
5.8 India Chagas Disease Drug Market Analysis
5.8.1 India Chagas Disease Drug Production
5.8.2 India Chagas Disease Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Chagas Disease Drug Import and Export
6 Chagas Disease Drug Segment Market Analysis (by Type)
6.1 Global Chagas Disease Drug Production by Type
6.2 Global Chagas Disease Drug Revenue by Type
6.3 Chagas Disease Drug Price by Type
7 Chagas Disease Drug Segment Market Analysis (by Application)
7.1 Global Chagas Disease Drug Consumption by Application
7.2 Global Chagas Disease Drug Consumption Market Share by Application (2014-2019)
8 Chagas Disease Drug Major Manufacturers Analysis
8.1 AstraZeneca Plc
8.1.1 AstraZeneca Plc Chagas Disease Drug Production Sites and Area Served
8.1.2 AstraZeneca Plc Product Introduction, Application and Specification
8.1.3 AstraZeneca Plc Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bayer AG
8.2.1 Bayer AG Chagas Disease Drug Production Sites and Area Served
8.2.2 Bayer AG Product Introduction, Application and Specification
8.2.3 Bayer AG Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Daiichi Sankyo Co Ltd
8.3.1 Daiichi Sankyo Co Ltd Chagas Disease Drug Production Sites and Area Served
8.3.2 Daiichi Sankyo Co Ltd Product Introduction, Application and Specification
8.3.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Eisai Co Ltd
8.4.1 Eisai Co Ltd Chagas Disease Drug Production Sites and Area Served
8.4.2 Eisai Co Ltd Product Introduction, Application and Specification
8.4.3 Eisai Co Ltd Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 GlaxoSmithKline Plc
8.5.1 GlaxoSmithKline Plc Chagas Disease Drug Production Sites and Area Served
8.5.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
8.5.3 GlaxoSmithKline Plc Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Grupo Praxis Pharmaceutical SA
8.6.1 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production Sites and Area Served
8.6.2 Grupo Praxis Pharmaceutical SA Product Introduction, Application and Specification
8.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Humanigen Inc
8.7.1 Humanigen Inc Chagas Disease Drug Production Sites and Area Served
8.7.2 Humanigen Inc Product Introduction, Application and Specification
8.7.3 Humanigen Inc Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Kancera AB
8.8.1 Kancera AB Chagas Disease Drug Production Sites and Area Served
8.8.2 Kancera AB Product Introduction, Application and Specification
8.8.3 Kancera AB Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Merck & Co Inc
8.9.1 Merck & Co Inc Chagas Disease Drug Production Sites and Area Served
8.9.2 Merck & Co Inc Product Introduction, Application and Specification
8.9.3 Merck & Co Inc Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Novartis AG
8.10.1 Novartis AG Chagas Disease Drug Production Sites and Area Served
8.10.2 Novartis AG Product Introduction, Application and Specification
8.10.3 Novartis AG Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Oblita Therapeutics BVBA
8.12 Sanofi
9 Development Trend of Analysis of Chagas Disease Drug Market
9.1 Global Chagas Disease Drug Market Trend Analysis
9.1.1 Global Chagas Disease Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Chagas Disease Drug Regional Market Trend
9.2.1 North America Chagas Disease Drug Forecast 2019-2025
9.2.2 Europe Chagas Disease Drug Forecast 2019-2025
9.2.3 China Chagas Disease Drug Forecast 2019-2025
9.2.4 Japan Chagas Disease Drug Forecast 2019-2025
9.2.5 Southeast Asia Chagas Disease Drug Forecast 2019-2025
9.2.6 India Chagas Disease Drug Forecast 2019-2025
9.3 Chagas Disease Drug Market Trend (Product Type)
9.4 Chagas Disease Drug Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Chagas Disease Drug Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Chagas Disease Drug
Table Global Chagas Disease Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Chagas Disease Drug Production Market Share by Types in 2018
Figure Cz-007 Product Picture
Figure Cz-008 Product Picture
Figure D-121 Product Picture
Figure DNDI-0690 Product Picture
Figure EPLBS-1246 Product Picture
Figure EPLBS-967 Product Picture
Figure Others Product Picture
Table Global Chagas Disease Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Chagas Disease Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Chagas Disease Drug Revenue (Million USD) (2014-2025)
Figure Global Chagas Disease Drug Production (K Pcs) (2014-2025)
Figure North America Chagas Disease Drug Market Size (Million USD) (2014-2025)
Figure Europe Chagas Disease Drug Market Size (Million USD) (2014-2025)
Figure China Chagas Disease Drug Market Size (Million USD) (2014-2025)
Figure Japan Chagas Disease Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Chagas Disease Drug Market Size (Million USD) (2014-2025)
Figure India Chagas Disease Drug Market Size (Million USD) (2014-2025)
Table Chagas Disease Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Chagas Disease Drug in 2018
Figure Manufacturing Process Analysis of Chagas Disease Drug
Figure Industry Chain Structure of Chagas Disease Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Chagas Disease Drug Manufacturing Plants Distribution
Table Chagas Disease Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Chagas Disease Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Chagas Disease Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Chagas Disease Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Chagas Disease Drug Production Share by Manufacturers in 2018
Table Chagas Disease Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Chagas Disease Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Chagas Disease Drug Revenue Share by Manufacturers in 2018
Table Chagas Disease Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Chagas Disease Drug Production by Regions 2014-2019 (K Pcs)
Table Global Chagas Disease Drug Production Market Share by Regions 2014-2019
Figure Global Chagas Disease Drug Production Market Share by Regions in 2018
Table Global Chagas Disease Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Chagas Disease Drug Revenue Market Share by Regions 2014-2019
Figure Global Chagas Disease Drug Revenue Market Share by Regions in 2018
Table Global Chagas Disease Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Chagas Disease Drug Consumption Market Share by Regions 2014-2019
Figure North America Chagas Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Chagas Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Chagas Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Chagas Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Chagas Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Chagas Disease Drug Production, Consumption Import and Export (K Pcs)
Figure China Chagas Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Chagas Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Chagas Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Chagas Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Chagas Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Chagas Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Chagas Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Chagas Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Chagas Disease Drug Production, Consumption Import and Export (K Pcs)
Figure India Chagas Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Chagas Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Chagas Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Chagas Disease Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Chagas Disease Drug Market Share by Application (2014-2019)
Table AstraZeneca Plc Chagas Disease Drug Production Sites and Area Served
Table AstraZeneca Plc Chagas Disease Drug Product Introduction, Application and Specification
Table AstraZeneca Plc Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AstraZeneca Plc Chagas Disease Drug Production Growth Rate (2014-2019)
Table AstraZeneca Plc Chagas Disease Drug Production Market Share (2014-2019)
Figure AstraZeneca Plc Chagas Disease Drug Revenue Market Share (2014-2019)
Table AstraZeneca Plc Chagas Disease Drug Main Business and Markets Served
Table Bayer AG Chagas Disease Drug Production Sites and Area Served
Table Bayer AG Chagas Disease Drug Product Introduction, Application and Specification
Table Bayer AG Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer AG Chagas Disease Drug Production Growth Rate (2014-2019)
Table Bayer AG Chagas Disease Drug Production Market Share (2014-2019)
Figure Bayer AG Chagas Disease Drug Revenue Market Share (2014-2019)
Table Bayer AG Chagas Disease Drug Main Business and Markets Served
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Production Sites and Area Served
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Product Introduction, Application and Specification
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Production Growth Rate (2014-2019)
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Production Market Share (2014-2019)
Figure Daiichi Sankyo Co Ltd Chagas Disease Drug Revenue Market Share (2014-2019)
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Main Business and Markets Served
Table Eisai Co Ltd Chagas Disease Drug Production Sites and Area Served
Table Eisai Co Ltd Chagas Disease Drug Product Introduction, Application and Specification
Table Eisai Co Ltd Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Co Ltd Chagas Disease Drug Production Growth Rate (2014-2019)
Table Eisai Co Ltd Chagas Disease Drug Production Market Share (2014-2019)
Figure Eisai Co Ltd Chagas Disease Drug Revenue Market Share (2014-2019)
Table Eisai Co Ltd Chagas Disease Drug Main Business and Markets Served
Table GlaxoSmithKline Plc Chagas Disease Drug Production Sites and Area Served
Table GlaxoSmithKline Plc Chagas Disease Drug Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Chagas Disease Drug Production Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Chagas Disease Drug Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Chagas Disease Drug Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Chagas Disease Drug Main Business and Markets Served
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production Sites and Area Served
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product Introduction, Application and Specification
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production Growth Rate (2014-2019)
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production Market Share (2014-2019)
Figure Grupo Praxis Pharmaceutical SA Chagas Disease Drug Revenue Market Share (2014-2019)
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Main Business and Markets Served
Table Humanigen Inc Chagas Disease Drug Production Sites and Area Served
Table Humanigen Inc Chagas Disease Drug Product Introduction, Application and Specification
Table Humanigen Inc Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Humanigen Inc Chagas Disease Drug Production Growth Rate (2014-2019)
Table Humanigen Inc Chagas Disease Drug Production Market Share (2014-2019)
Figure Humanigen Inc Chagas Disease Drug Revenue Market Share (2014-2019)
Table Humanigen Inc Chagas Disease Drug Main Business and Markets Served
Table Kancera AB Chagas Disease Drug Production Sites and Area Served
Table Kancera AB Chagas Disease Drug Product Introduction, Application and Specification
Table Kancera AB Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Kancera AB Chagas Disease Drug Production Growth Rate (2014-2019)
Table Kancera AB Chagas Disease Drug Production Market Share (2014-2019)
Figure Kancera AB Chagas Disease Drug Revenue Market Share (2014-2019)
Table Kancera AB Chagas Disease Drug Main Business and Markets Served
Table Merck & Co Inc Chagas Disease Drug Production Sites and Area Served
Table Merck & Co Inc Chagas Disease Drug Product Introduction, Application and Specification
Table Merck & Co Inc Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co Inc Chagas Disease Drug Production Growth Rate (2014-2019)
Table Merck & Co Inc Chagas Disease Drug Production Market Share (2014-2019)
Figure Merck & Co Inc Chagas Disease Drug Revenue Market Share (2014-2019)
Table Merck & Co Inc Chagas Disease Drug Main Business and Markets Served
Table Novartis AG Chagas Disease Drug Production Sites and Area Served
Table Novartis AG Chagas Disease Drug Product Introduction, Application and Specification
Table Novartis AG Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Chagas Disease Drug Production Growth Rate (2014-2019)
Table Novartis AG Chagas Disease Drug Production Market Share (2014-2019)
Figure Novartis AG Chagas Disease Drug Revenue Market Share (2014-2019)
Table Novartis AG Chagas Disease Drug Main Business and Markets Served
Table Oblita Therapeutics BVBA Chagas Disease Drug Production Sites and Area Served
Table Sanofi Chagas Disease Drug Production Sites and Area Served
Figure Global Chagas Disease Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Chagas Disease Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Chagas Disease Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Chagas Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Chagas Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Chagas Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Chagas Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Chagas Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Chagas Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Chagas Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Chagas Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Chagas Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Chagas Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Chagas Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Chagas Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Chagas Disease Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Chagas Disease Drug by Application (2019-2025)
Table Chagas Disease Drug Distributors List
Table Chagas Disease Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
クローン病薬のグローバル市場調査 2019年 The global Crohn’s Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Crohn’s Disease Drug volume and value at global level, regional level and company level. From a global perspective, th…- デビック病薬のグローバル市場調査 2019年 The global Devic's Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Devic's Disease Drug volume and value at global level, regional level and company level. From a global perspective, th…
- セリアック病治療薬のグローバル市場調査 2019年 The global Celiac Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Celiac Disease Drug volume and value at global level, regional level and company level. From a global perspective, this…
- 世界及び中国の胃食道逆流疾患 (GERD) 治療薬市場2018 The 'Global and Chinese Gastro Esophageal Reflux Disease (GERD) Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Gastro Esophageal Reflux Disease (GERD) Drug industry with a focus on the Chinese market. The report provides key s…
- クローン病治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Crohn’s disease is a kind of inflammatory bowel sickness (IBD), caused by a mixture of environmental, immune and bacterial elements in genetically prone individuals. Scope of the Report: This report focuses on the Crohn’s Disease Drug in global market, especially in North America, Europe and Asia-Pa…